"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate. Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease." Scope of the Report: This report focuses on the Onychomycosis (Tinea Unguium) Drug in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Johnson & Johnson GSK Novartis Pfizer Valeant Pharma Kaken Pharmaceutical Galderma Xiuzheng Pharmaceutical Letai Qilu Pharmaceutical Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Oral External Market Segment by Applications, can be divided into Age under 18 Age 18-50 Age above 50 There are 17 Chapters to deeply display the United States Onychomycosis (Tinea Unguium) Drug market. Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Onychomycosis (Tinea Unguium) Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Onychomycosis (Tinea Unguium) Drug, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Onychomycosis (Tinea Unguium) Drug market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Onychomycosis (Tinea Unguium) Drug Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents 1 Market Overview 1.1 Onychomycosis (Tinea Unguium) Drug Introduction 1.2 Market Analysis by Type 1.2.1 Oral 1.2.2 External 1.3 Market Analysis by Applications 1.3.1 Age under 18 1.3.2 Age 18-50 1.3.3 Age above 50 1.4 Market Analysis by States 1.4.1 California Status and Prospect (2012-2022) 1.4.2
